In vitro generated human memory-like T cells are CD95 type II cells and resistant towards CD95-mediated apoptosis

European Journal of Immunology

Volumn 36, Issue 11, 2006, Pages 2894-2903

  Fas, Stefanie C ^a,b   Baumann, Sven ^a,c   Krueger, Andreas ^a,d   Frey, Christian R ^a   Schulze Bergkamen, Henning ^a,e   Brenner, Dirk ^a   Stumpf, Christine ^a   Kappes, Kathrin ^a   Krammer, Peter H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Kenta Biotech AG   (Switzerland)

^c MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Apoptosis; Memory cells; T cells

Indexed keywords

CD3 ANTIGEN; FAS ANTIGEN; PROTEIN BCL 2; PROTEIN BCL XL; T LYMPHOCYTE RECEPTOR;

APOPTOSIS; ARTICLE; BYSTANDER EFFECT; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE CULTURE; MEMORY T LYMPHOCYTE; MITOCHONDRION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD95; APOPTOSIS; BCL-X PROTEIN; CELL CULTURE TECHNIQUES; CELLS, CULTURED; FAS LIGAND PROTEIN; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-BCL-2; T-LYMPHOCYTES; UP-REGULATION;

EID: 33751243926     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200635925     Document Type: Article

References (47)

1. Alderson, M. R., Tough, T. W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G. et al., Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 1995. 181: 71-77.
2. Dhein, J., Walczak, H., Baumler, C., Debatin, K. M. and Krammer, P. H., Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995. 373: 438-441.
3. Ju, S. T., Panka, D. J., Cui, H., Ettinger, R., el-Khatib, M., Sherr, D. H., Stanger, B. Z. and Marshak-Rothstein, A., Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995. 373: 444-448.
4. Krueger, A., Fas, S. C., Baumann, S. and Krammer, P. H., The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol. Rev. 2003. 193: 58-69.
5. Krammer, P.H., CD95's deadly mission in the immune system. Nature 2000. 407: 789-795.
6. Hildeman, D. A., Zhu, Y., Mitchell, T. C., Kappler, J. and Marrack, P., Molecular mechanisms of activated T cell death in vivo. Curr. Opin. Immunol. 2002. 14: 354-359.
7. Peter, M. E. and Krammer, P. H., The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 2003. 10: 26-35.
8. Medema, J. P., Scaffidi, C., Kischkel, F. C., Shevchenko, A., Mann, M., Krammer, P. H. and Peter, M. E., FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 1997. 16: 2794-2804.
9. Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K. M. et al., Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 1998. 17: 1675-1687
10. Li, H., Zhu, H., Xu, C. J. and Yuan, J., Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998. 94: 491-501.
11. Luo, X., Budihardjo, I., Zou, H., Slaughter, C. and Wang, X., Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998. 94: 481-490.
12. Klas, C., Debatin, K. M., Jonker, R. R. and Krammer, P. H., Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 1993. 5: 625-630.
13. Peter, M. E., Kischkel, F. C., Scheuerpflug, C. G., Medema, J. P., Debatin, K. M. and Krammer, P. H., Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex. Eur. J. Immunol. 1997. 27: 1207-1212.
14. Schmitz, L, Krueger, A., Baumann, S., Schulze-Bergkamen, H., Krammer, P. H. and Kirchhoff, S., An IL-2-dependent switch between CD95 signaling pathways sensitizes primary human T cells toward CD95-mediated activation-induced cell death. J. Immunol. 2003. 171: 2930-2936.
15. Scaffidi, C., Schmitz, I., Krammer, P. H. and Peter, M. E., The role of c-FLIP in modulation of CD95-induced apoptosis. J. Biol. Chem. 1999. 274: 1541-1548.
16. Dutton, R. W., Bradley, L. M. and Swain, S. L., T cell memory. Annu. Rev. Immunol. 1998. 16: 201-223.
17. Sprent, J. and Surh, C. D., T cell memory. Annu. Rev. Immunol. 2002. 20: 551-579.
18. Rogers, P. R., Dubey, C. and Swain, S. L., Qualitative changes accompany memory T cell generation: faster, more effective responses at lower doses of antigen. J. Immunol. 2000. 164: 2338-2346.
19. Sallusto, F., Geginat, J. and Lanzavecchia, A., Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 2004. 22: 745-763.
20. Murali-Krishna, K., Lau, L. L., Sambhara, S., Lemonnier, F., Altman, J. and Ahmed, R., Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 1999. 286: 1377-1381.
21. Swain, S. L, Hu, H. and Huston, G., Class II-independent generation of CD4 memory T cells from effectors. Science 1999. 286: 1381-1383.
22. Bourgeois, C., Veiga-Fernandes, H., Joret, A. M., Rocha, B. and Tanchot C., CD8 lethargy in the absence of CD4 help. Eur. J. Immunol. 2002. 32: 2199-2207.
23. + T lymphocytes. Nature 2003. 421: 852-856.
24. Shedlock, D. J. and Shen, H., Requirement for CD4 Tcell help in generating functional CD8 T cell memory. Science 2003. 300: 337-339.
25. Sun, J. C. and Bevan, M. J., Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003. 300: 339-342.
26. + cells but are not required for memory phenotype CD4+ cells. J. Exp. Med. 2002. 195: 1523-1532.
27. + T cells in vivo by IL-15. Immunity 1998. 8: 591-599.
28. + memory T cells. Proc. Natl. Acad. Sci. USA 2002. 99: 6192-6197.
29. Schluns, K. S., Kieper, W. C., Jameson, S. C. and Lefrancois, L., Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 2000. 1: 426-432.
30. Seddon, B., Tomlinson, P. and Zamoyska, R., Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat. Immunol. 2003. 4: 680-686.
31. Arlettaz, I., Barbey, C., Dumont-Girard, F., Helg, C., Chapuis, B., Roux, E. and Roosnek, E., CD45 isoform phenotypes of human T cells: CD4(+)CD45RA(-)RO(+) memory T cells re-acquire CD45RA without losing CD45RO. Eur. J. Immunol. 1999. 29: 3987-3994.
32. + T cells comprise both naive and memory cells. J. Immunol. 1999. 162: 7080-7087.
33. Dunne, P. J., Faint, J. M., Gudgeon, N. H., Fletcher, J. M., Plunkett, F. J., Soares, M. V., Hislop, A. D. et al., Epstein-Barr virus-specific CD8(+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential. Blood 2002. 100: 933-940.
34. Krueger, A., Baumann, S., Krammer, P. H. and Kirchhoff, S., FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. Mol. Cell. Biol. 2001. 21: 8247-8254.
35. Eichhorst, S. T., Krueger, A., Muerkoster, S., Fas, S. C., Golks, A., Gruetzner, U., Schubert, L. et al., Suramin inhibits death receptor-induced apoptosis in vitro and fulminant apoptotic liver damage in mice. Nat. Med. 2004. 10: 602-609.
36. Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann K., Steiner, V., Bodmer, J. L. et al., Inhibition of death receptor signals by cellular FLIP. Nature 1997. 388: 190-195.
37. Krueger, A., Schmitz, I., Baumann, S., Krammer, P. H. and Kirchhoff, S., Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J. Biol. Chem. 2001. 276: 20633-20640.
38. Schmitz, I., Weyd, H., Krueger A., Baumann, S., Fas, S. C., Krammer, P. H. and Kirchhoff, S., Resistance of short term activated T cells to CD95-mediated apoptosis correlates with de novo protein synthesis of c-FLIPshort. J. Immunol. 2004. 172: 2194-2200.
39. Kirchhoff, S., Muller, W. W., Krueger, A., Schmitz, I. and Krammer, P. H., TCR-mediated up-regulation of c-FlIPshort correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity. J. Immunol. 2000. 165: 6293-6300.
40. Kirchhoff, S., Muller, W. W., Li-Weber, M. and Krammer, P. H., Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-costimulated human T cells. Eur. J. Immunol. 2000. 30: 2765-2774.
41. Strauss, G., Knape, I., Melzner, I. and Debadn, K. M., Constitutive caspase activation and imapaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells. J. Immunol. 2003. 171: 1172-1182.
42. Kreuz, S., Siegmund, D., Scheurich, P. and Wedant, H., NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol. Cell. Biol. 2001. 21: 3964-3973.
43. Micheau, O., Lens, S., Gaide, O., Alevizopoulos, K. and Tschopp, J., NF-kappaB signals induce the expression of c-FLIP. Mol. Cell. Biol. 2001. 21: 5299-5305.
44. Scaffidi C., Medema, J. P., Krammer, P. H. and Peter, M. E., FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J. Biol. Chem. 1997. 272: 26953-26958.
45. Trauth, B. C., Klas, C., Peters, A. M., Matzku, S., Moller, P., Falk, W., Debatin, K. M. and Krammer, P. H., Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989. 245: 301-305.
46. Walczak H., Miller, R. E., Ariail, K., Gliniak B., Griffith, T. S., Kubin, M., Chin, W. et al., Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med. 1999. 5: 157-163.
47. Scaffidi C., Kischkel, F. C., Krammer, P. H. and Peter, M. E., Analysis of the CD95 (APO-1/Fas) death-inducing signaling complex by high-resolution two-dimensional gel electrophoresis. Methods Enzymol. 2000. 322: 363-373.